Pharma Biz Buys Animal Medicine Co. For Up To $520M
By Jade Martinez-Pogue · July 18, 2024, 3:23 PM EDT
Latham & Watkins LLP-advised animal health therapeutics company Invetx, which is currently owned by life sciences-focused investment management firm Novo Holdings, on Thursday announced plans to be bought by veterinary pharmaceuticals...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login